US68375N1037
US68375N1037
Opko Health, Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 1.03B EUR | 1.12B EUR | 860.81M EUR | 956.43M EUR |
Enterprise Value | 1.12B EUR | 1.22B EUR | 915.85M EUR | 984.13M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -5.11x | -- | -- | -- |
Price to Sales | 1.75x | 1.9x | 1.48x | 2.09x |
Price to Book | 0.87x | 0.94x | 0.71x | 0.75x |
EV/Revenue | 1.91x | 2.07x | 1.58x | 2.15x |
EV/EBITDA | -14.33x | -- | -- | -- |
Price to FCF (P/FCF) | 18.81x | -- | -- | -- |
EV/FCF | 20.45x | -- | -- | -- |
FCF Yield | 5.32% | -11.98% | -20.24% | -16% |